molecularAlterationType,datatype,name,description,showProfileInAnalysisTab,molecularProfileId,studyId
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"acbc_mskcc_2015_cna","acbc_mskcc_2015"
"MUTATION_EXTENDED","MAF","Mutations","Whole exome sequencing of 12 breast AdCCs.",true,"acbc_mskcc_2015_mutations","acbc_mskcc_2015"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"acc_tcga_rppa","acc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"acc_tcga_rppa_Zscores","acc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 90 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"acc_tcga_gistic","acc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 79 acc cases (RNA Seq V2 RSEM).",false,"acc_tcga_rna_seq_v2_mrna","acc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"acc_tcga_rna_seq_v2_mrna_median_Zscores","acc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"acc_tcga_linear_CNA","acc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 80 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"acc_tcga_methylation_hm450","acc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: ACC/20160128/gdac.broadinstitute.org_ACC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"acc_tcga_mutations","acc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"acc_tcga_pan_can_atlas_2018_gistic","acc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"acc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","acc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"acc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","acc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"acc_tcga_pan_can_atlas_2018_log2CNA","acc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"acc_tcga_pan_can_atlas_2018_mutations","acc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"acyc_fmi_2014_cna","acyc_fmi_2014"
"MUTATION_EXTENDED","MAF","Mutations","Comprehensive genomic profiling of 28 metastatic ACCs.",true,"acyc_fmi_2014_mutations","acyc_fmi_2014"
"MUTATION_EXTENDED","MAF","Mutations","WGS of 28 primary salivary ACCs",true,"acyc_mda_2015_mutations","acyc_mda_2015"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"acyc_mskcc_2013_cna","acyc_mskcc_2013"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 60 tumor/normal pairs.",true,"acyc_mskcc_2013_mutations","acyc_mskcc_2013"
"MUTATION_EXTENDED","MAF","Mutations","Whole exome sequencing of 24 ACCs.",true,"acyc_sanger_2013_mutations","acyc_sanger_2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 782 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"all_phase2_target_2018_pub_cna","all_phase2_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA-Seq RPKM)","Expression levels for 26136 genes in 203 all cases (RNA-Seq RPKM).",false,"all_phase2_target_2018_pub_rna_seq_mrna","all_phase2_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"all_phase2_target_2018_pub_rna_seq_mrna_median_Zscores","all_phase2_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","mRNA expression levels (Affymetrix microarray)",false,"all_phase2_target_2018_pub_mrna","all_phase2_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"all_phase2_target_2018_pub_mrna_median_Zscores","all_phase2_target_2018_pub"
"METHYLATION","CONTINUOUS","Methylation (hm27)","Methylation beta-values (hm27 assay). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"all_phase2_target_2018_pub_methylation_hm27","all_phase2_target_2018_pub"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from whole genome or whole exome sequencing on 298 samples.",true,"all_phase2_target_2018_pub_mutations","all_phase2_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"all_phase2_target_2018_pub_mirna","all_phase2_target_2018_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status from exome sequencing in 44 samples.",true,"all_stjude_2013_mutations","all_stjude_2013"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome sequencing(WGS) of 22 infant MLL-rearranged acute lymphoblastic leukemia(MLL-R ALL) cases.",true,"all_stjude_2015_mutations","all_stjude_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from WGS/WES.",true,"all_stjude_2016_mutations","all_stjude_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"aml_target_2018_pub_cna","aml_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA-Seq RPKM)","Expression levels for genes in TARGET-AML Discovery cases (RNA-Seq RPKM).",false,"aml_target_2018_pub_rna_seq_mrna","aml_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression (microarray)","mRNA expression levels (Affymetrix microarray)",false,"aml_target_2018_pub_mrna_median_Zscores","aml_target_2018_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (HM27 platform). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"aml_target_2018_pub_methylation_hm27","aml_target_2018_pub"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from whole genome or whole exome sequencing on 333 samples.",true,"aml_target_2018_pub_mutations","aml_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"aml_target_2018_pub_mirna","aml_target_2018_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing analysis of 160 cancers arising in the periampullary region, 62 of these clearly arising from either the bile duct (n = 44) or the duodenum (n = 18) and 98 for which the epithelium of origin could not be clearly defined morphologically (AMPAC).",true,"ampca_bcm_2016_mutations","ampca_bcm_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"angs_project_painter_2018_gistic","angs_project_painter_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from 103 WES samples.",true,"angs_project_painter_2018_mutations","angs_project_painter_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 22 phyllodes tumors.",true,"bfn_duke_nus_2015_mutations","bfn_duke_nus_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from Exome and whole-genome sequencing of 99 bladder cancer samples.",true,"blca_bgi_mutations","blca_bgi"
"COPY_NUMBER_ALTERATION","DISCRETE","Copy Number Alterations","Copy number alterations",true,"blca_cornell_2016_cna","blca_cornell_2016"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values adjusted by ploidy and purity with CLONET","Log2 copy-number values for each gene adjusted by ploidy and purity with CLONET.",false,"blca_cornell_2016_log2CNA","blca_cornell_2016"
"MUTATION_EXTENDED","MAF","Mutations","WXS of 72 samples",true,"blca_cornell_2016_mutations","blca_cornell_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status from whole exome sequencing.",true,"blca_dfarber_mskcc_2014_mutations","blca_dfarber_mskcc_2014"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (RAE)","Putative copy-number calls in 97 samples determined using standard RAE on Agilent 1M data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_mskcc_solit_2012_cna","blca_mskcc_solit_2012"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression (Illumina)","mRNA expression values on 60 samples (Illumina microarrays)",false,"blca_mskcc_solit_2012_mrna","blca_mskcc_solit_2012"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression z-scores (Illumina)","mRNA expression z-scores on 60 samples (Illumina microarrays)",true,"blca_mskcc_solit_2012_zscores","blca_mskcc_solit_2012"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (Infinium HumanMethylation27 platform). For genes with multiple methylation probes, the probe most negatively correlated with expression is used.",false,"blca_mskcc_solit_2012_methylation_hm27","blca_mskcc_solit_2012"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status of AKT1, AKT3, BRAF, CDKN2A, FGFR3, KRAS, PIK3CA, PIK3R1, PTEN, RB1, TP53, and TSC1 in 97 samples.",true,"blca_mskcc_solit_2012_mutations","blca_mskcc_solit_2012"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (IMPACT)","Putative copy-number calls derived from IMPACT data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_mskcc_solit_2014_cna","blca_mskcc_solit_2014"
"COPY_NUMBER_ALTERATION","LOG-VALUE","Log2 copy-number values","Log2 copy-number values for each gene.",false,"blca_mskcc_solit_2014_log2CNA","blca_mskcc_solit_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status from targeted sequencing (IMPACT assay).",true,"blca_mskcc_solit_2014_mutations","blca_mskcc_solit_2014"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Copy Number data",true,"blca_nmibc_2017_cna","blca_nmibc_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from next-gen sequencing.",true,"blca_nmibc_2017_mutations","blca_nmibc_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","MSK-IMPACT Clinical Sequencing Cohort (MSKCC)  blca_mskcc_signet_ring  Putative copy-number alterations (IMPACT)","Putative copy-number calls derived from IMPACT data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_plasmacytoid_mskcc_2016_cna","blca_plasmacytoid_mskcc_2016"
"MUTATION_EXTENDED","MAF","Bladder Cancer, Plasmacytoid Variant (MSKCC, Nat Gen 2016)","Genomic profiling of plasmacytoid-variant (signet ring cell) tumors of the bladder, published set.",true,"blca_plasmacytoid_mskcc_2016_mutations","blca_plasmacytoid_mskcc_2016"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"blca_tcga_rppa","blca_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"blca_tcga_rppa_Zscores","blca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 408 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_tcga_gistic","blca_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 427 blca cases (RNA Seq V2 RSEM).",false,"blca_tcga_rna_seq_v2_mrna","blca_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"blca_tcga_rna_seq_v2_mrna_median_Zscores","blca_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"blca_tcga_linear_CNA","blca_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 434 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"blca_tcga_methylation_hm450","blca_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: BLCA/20160128/gdac.broadinstitute.org_BLCA.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"blca_tcga_mutations","blca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_tcga_pan_can_atlas_2018_gistic","blca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"blca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","blca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"blca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","blca_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"blca_tcga_pan_can_atlas_2018_log2CNA","blca_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"blca_tcga_pan_can_atlas_2018_mutations","blca_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"blca_tcga_pub_rppa","blca_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"blca_tcga_pub_rppa_Zscores","blca_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 182 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_tcga_pub_gistic","blca_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 182 blca cases (RNA Seq V2 RSEM).",false,"blca_tcga_pub_rna_seq_v2_mrna","blca_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"blca_tcga_pub_rna_seq_mrna_median_Zscores","blca_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"blca_tcga_pub_linear_CNA","blca_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 201 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"blca_tcga_pub_methylation_hm450","blca_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"blca_tcga_pub_mutations","blca_tcga_pub"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"blca_tcga_pub_2017_rppa","blca_tcga_pub_2017"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"blca_tcga_pub_2017_rppa_Zscores","blca_tcga_pub_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 408 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"blca_tcga_pub_2017_gistic","blca_tcga_pub_2017"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 427 blca cases (RNA Seq V2 RSEM).",false,"blca_tcga_pub_2017_rna_seq_v2_mrna","blca_tcga_pub_2017"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"blca_tcga_pub_2017_rna_seq_v2_mrna_median_Zscores","blca_tcga_pub_2017"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"blca_tcga_pub_2017_linear_CNA","blca_tcga_pub_2017"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 434 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"blca_tcga_pub_2017_methylation_hm450","blca_tcga_pub_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"blca_tcga_pub_2017_mutations","blca_tcga_pub_2017"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 65 tumor/normal pairs.",true,"brca_bccrc_mutations","brca_bccrc"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for the Breast Xenograft Evolution study.",false,"brca_bccrc_xenograft_2014_log2CNA","brca_bccrc_xenograft_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data for the Breast Xenograft Evolution study.",true,"brca_bccrc_xenograft_2014_mutations","brca_bccrc_xenograft_2014"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 103 tumor/normal pairs.",true,"brca_broad_mutations","brca_broad"
"COPY_NUMBER_ALTERATION","DISCRETE","Copy number alterations","Copy number calls.Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_igr_2015_cna","brca_igr_2015"
"MUTATION_EXTENDED","MAF","Whole exome sequencing","Whole exome sequencing of 213 metastatic breast samples.",true,"brca_igr_2015_mutations","brca_igr_2015"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_mbcproject_wagle_2017_gistic","brca_mbcproject_wagle_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from 103 WES samples.",true,"brca_mbcproject_wagle_2017_mutations","brca_mbcproject_wagle_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from DNAcopy.","Copy-number alterations from DNA copy. Calls made after normal contamination correction and CNV removal using thresholds. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_metabric_cna","brca_metabric"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression log intensity levels (Illumina Human v3 microarray)",false,"brca_metabric_mrna","brca_metabric"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (Illumina Human v3 microarray)","mRNA z-Scores  (Illumina Human v3 microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_metabric_mrna_U133_Zscores","brca_metabric"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from targeted sequencing of 173 genes.",true,"brca_metabric_mutations","brca_metabric"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 100 tumor/normal pairs.",true,"brca_sanger_mutations","brca_sanger"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"brca_tcga_rppa","brca_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"brca_tcga_rppa_Zscores","brca_tcga"
"PROTEIN_LEVEL","CONTINUOUS","Protein levels (mass spectrometry by CPTAC)","Protein levels measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",false,"brca_tcga_protein_quantification","brca_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein level Z-scores (mass spectrometry by CPTAC)","Protein level Z-scores measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",true,"brca_tcga_protein_quantification_zscores","brca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 1080 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_tcga_gistic","brca_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 590 brca cases (Agilent microarray).",false,"brca_tcga_mrna","brca_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_tcga_mrna_median_Zscores","brca_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 1212 brca cases (RNA Seq V2 RSEM).",false,"brca_tcga_rna_seq_v2_mrna","brca_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_tcga_rna_seq_v2_mrna_median_Zscores","brca_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"brca_tcga_linear_CNA","brca_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 885 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"brca_tcga_methylation_hm450","brca_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: BRCA/20160128/gdac.broadinstitute.org_BRCA.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"brca_tcga_mutations","brca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_tcga_pan_can_atlas_2018_gistic","brca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"brca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","brca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"brca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","brca_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"brca_tcga_pan_can_atlas_2018_log2CNA","brca_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"brca_tcga_pan_can_atlas_2018_mutations","brca_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"brca_tcga_pub_rppa","brca_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"brca_tcga_pub_rppa_Zscores","brca_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_tcga_pub_gistic","brca_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels (Agilent microarray).",false,"brca_tcga_pub_mrna","brca_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_tcga_pub_mrna_median_Zscores","brca_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"brca_tcga_pub_linear_CNA","brca_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (HM27 platform). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"brca_tcga_pub_methylation_hm27","brca_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"brca_tcga_pub_mutations","brca_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"brca_tcga_pub_mirna","brca_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"brca_tcga_pub_mirna_median_Zscores","brca_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",true,"brca_tcga_pub_mrna_merged_median_Zscores","brca_tcga_pub"
"PROTEIN_LEVEL","CONTINUOUS","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"brca_tcga_pub2015_protein_quantification","brca_tcga_pub2015"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"brca_tcga_pub2015_rppa_Zscores","brca_tcga_pub2015"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 1080 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"brca_tcga_pub2015_gistic","brca_tcga_pub2015"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17157 genes in 590 brca cases (Agilent microarray).",false,"brca_tcga_pub2015_mrna","brca_tcga_pub2015"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_tcga_pub2015_mrna_median_Zscores","brca_tcga_pub2015"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 1212 brca cases (RNA Seq V2 RSEM).",false,"brca_tcga_pub2015_rna_seq_v2_mrna","brca_tcga_pub2015"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"brca_tcga_pub2015_rna_seq_v2_mrna_median_Zscores","brca_tcga_pub2015"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number valuesdata_filename: data_linear_CNA.txt","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"brca_tcga_pub2015_linear_CNA","brca_tcga_pub2015"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 343 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"brca_tcga_pub2015_methylation_hm27","brca_tcga_pub2015"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 869 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"brca_tcga_pub2015_methylation_hm450","brca_tcga_pub2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"brca_tcga_pub2015_mutations","brca_tcga_pub2015"
"COPY_NUMBER_ALTERATION","DISCRETE","copy-number alterations","Discrete copy-number data from IMPACT",true,"breast_msk_2018_cna","breast_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from IMPACT testing",true,"breast_msk_2018_mutations","breast_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from multi region exome sequencing (M-seq) of 10 clear cell renal carcinomas(ccRCCs).",true,"ccrcc_irc_2014_mutations","ccrcc_irc_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome and(or) whole exome sequencing of 240 clear-cell renal cell carcinoma samples.",true,"ccrcc_utokyo_2013_mutations","ccrcc_utokyo_2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls in 972 samples determined by GISTIC2: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification. GISTIC2 was run using the GenePattern website, using the CCLE segmented data downloaded from the CCLE website and all the default parameters, except the confidence, which we increased from 0.75 to 0.99.",true,"cellline_ccle_broad_cna","cellline_ccle_broad"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 16219 genes in 991 samples (Affymetrix microarray).",false,"cellline_ccle_broad_mrna","cellline_ccle_broad"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Affymetrix microarray)",true,"cellline_ccle_broad_mrna_median_Zscores","cellline_ccle_broad"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"cellline_ccle_broad_log2CNA","cellline_ccle_broad"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from targeted sequencing (1561 genes).",true,"cellline_ccle_broad_mutations","cellline_ccle_broad"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from discretization","Putative copy-number calls in 60 samples: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification. Putative copy-number calls in 972 samples determined by GISTIC2: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification. GISTIC2 was run using the GenePattern website.",true,"cellline_nci60_cna","cellline_nci60"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (combined microarray)","mRNA z-Scores (5 Platform Gene Transcript)",true,"cellline_nci60_mrna_median_Zscores","cellline_nci60"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"cellline_nci60_linear_CNA","cellline_nci60"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing (includes only type-2 mutations).",true,"cellline_nci60_mutations","cellline_nci60"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"cesc_tcga_rppa","cesc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"cesc_tcga_rppa_Zscores","cesc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 295 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"cesc_tcga_gistic","cesc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 309 cesc cases (RNA Seq V2 RSEM).",false,"cesc_tcga_rna_seq_v2_mrna","cesc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"cesc_tcga_rna_seq_v2_mrna_median_Zscores","cesc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"cesc_tcga_linear_CNA","cesc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 312 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"cesc_tcga_methylation_hm450","cesc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: CESC/20160128/gdac.broadinstitute.org_CESC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"cesc_tcga_mutations","cesc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"cesc_tcga_pan_can_atlas_2018_gistic","cesc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"cesc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","cesc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"cesc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","cesc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"cesc_tcga_pan_can_atlas_2018_log2CNA","cesc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"cesc_tcga_pan_can_atlas_2018_mutations","cesc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Exomic Sequencing of 32 cases of intrahepatic cholangiocarcinomas and  8 cases of Gall Bladder.",true,"chol_jhu_2013_mutations","chol_jhu_2013"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 15 cases.",true,"chol_nccs_2013_mutations","chol_nccs_2013"
"MUTATION_EXTENDED","MAF","Mutations","Exomic Sequencing of 8 cases of Opisthorchis viverrini-related cholangiocarcinoma.",true,"chol_nus_2012_mutations","chol_nus_2012"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"chol_tcga_rppa","chol_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"chol_tcga_rppa_Zscores","chol_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 36 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"chol_tcga_gistic","chol_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 45 chol cases (RNA Seq V2 RSEM).",false,"chol_tcga_rna_seq_v2_mrna","chol_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"chol_tcga_rna_seq_v2_mrna_median_Zscores","chol_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"chol_tcga_linear_CNA","chol_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 45 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"chol_tcga_methylation_hm450","chol_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: CHOL/20160128/gdac.broadinstitute.org_CHOL.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"chol_tcga_mutations","chol_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"chol_tcga_pan_can_atlas_2018_gistic","chol_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"chol_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","chol_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"chol_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","chol_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"chol_tcga_pan_can_atlas_2018_log2CNA","chol_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"chol_tcga_pan_can_atlas_2018_mutations","chol_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of CLL tumor/normal pairs.",true,"cllsll_icgc_2011_mutations","cllsll_icgc_2011"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-genome(WGS) or whole-exome(WXS) sequencing of 428 CLL, 54 MBL, and 24 SLL samples.",true,"cll_iuopa_2015_mutations","cll_iuopa_2015"
"MUTATION_EXTENDED","MAF","Mutations","Whole-exome sequencing of 619 colorectal cancers with clinicopathologic annotations",true,"coadread_dfci_2016_mutations","coadread_dfci_2016"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 72 tumor/normal pairs.",true,"coadread_genentech_mutations","coadread_genentech"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from 69 patients each having a primary and a metastatic mutation.",true,"coadread_mskcc_mutations","coadread_mskcc"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"coadread_tcga_rppa","coadread_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"coadread_tcga_rppa_Zscores","coadread_tcga"
"PROTEIN_LEVEL","CONTINUOUS","Protein levels (mass spectrometry by CPTAC)","Protein levels measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",false,"coadread_tcga_protein_quantification","coadread_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein level Z-scores (mass spectrometry by CPTAC)","Protein level Z-scores measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",true,"coadread_tcga_protein_quantification_zscores","coadread_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 616 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"coadread_tcga_gistic","coadread_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 244 coadread cases (Agilent microarray).",false,"coadread_tcga_mrna","coadread_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"coadread_tcga_mrna_median_Zscores","coadread_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 433 coadread cases (RNA Seq V2 RSEM).",false,"coadread_tcga_rna_seq_v2_mrna","coadread_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"coadread_tcga_rna_seq_v2_mrna_median_Zscores","coadread_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"coadread_tcga_linear_CNA","coadread_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 441 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"coadread_tcga_methylation_hm450","coadread_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: COADREAD/20160128/gdac.broadinstitute.org_COADREAD.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"coadread_tcga_mutations","coadread_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"coadread_tcga_pan_can_atlas_2018_gistic","coadread_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","coadread_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"coadread_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","coadread_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"coadread_tcga_pan_can_atlas_2018_log2CNA","coadread_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"coadread_tcga_pan_can_atlas_2018_mutations","coadread_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"coadread_tcga_pub_gistic","coadread_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq RPKM)","Expression levels (RNA Seq RPKM).",false,"coadread_tcga_pub_rna_seq_mrna","coadread_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"coadread_tcga_pub_rna_seq_mrna_median_Zscores","coadread_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels (Agilent microarray).",false,"coadread_tcga_pub_mrna","coadread_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"coadread_tcga_pub_mrna_median_Zscores","coadread_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"coadread_tcga_pub_linear_CNA","coadread_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (HM27 platform). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"coadread_tcga_pub_methylation_hm27","coadread_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"coadread_tcga_pub_mutations","coadread_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","expression levels for microRNAs.",false,"coadread_tcga_pub_mirna","coadread_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"coadread_tcga_pub_mirna_median_Zscores","coadread_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",false,"coadread_tcga_pub_mrna_merged_median_Zscores","coadread_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"crc_msk_2018_gistic","crc_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from MSK-IMPACT CRC.",true,"crc_msk_2018_mutations","crc_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from target sequencing of 504 cancer-associated genes on lymph node metastases in 29 patients with cutaneous squamous cell carcinomas.",true,"cscc_dfarber_2015_mutations","cscc_dfarber_2015"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutation data from whole exome sequencing of 39 cases of agressive cSCC samples.",true,"cscc_hgsc_bcm_2014_mutations","cscc_hgsc_bcm_2014"
"MUTATION_EXTENDED","MAF","Mutations","WXS Cohort",true,"ctcl_columbia_2015_mutations","ctcl_columbia_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from Exome/Whole Genome sequencing of 20 desmoplastic melanoma cases.",true,"desm_broad_2015_mutations","desm_broad_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing of 135 DLBCL samples.",true,"dlbcl_dfci_2018_mutations","dlbcl_dfci_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","copy-number values","copy number alterations from whole-exome sequencing data of 1,001 DLBCL patients",false,"dlbcl_duke_2017_log2CNA","dlbcl_duke_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutations from genomic profiling of 150 driver genes",true,"dlbcl_duke_2017_mutations","dlbcl_duke_2017"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole exome sequencing.",true,"dlbc_broad_2012_mutations","dlbc_broad_2012"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"dlbc_tcga_rppa","dlbc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"dlbc_tcga_rppa_Zscores","dlbc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 48 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"dlbc_tcga_gistic","dlbc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 48 dlbcl cases (RNA Seq V2 RSEM).",false,"dlbc_tcga_rna_seq_v2_mrna","dlbc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"dlbc_tcga_rna_seq_v2_mrna_median_Zscores","dlbc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"dlbc_tcga_linear_CNA","dlbc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 48 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"dlbc_tcga_methylation_hm450","dlbc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: DLBC/20160128/gdac.broadinstitute.org_DLBC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"dlbc_tcga_mutations","dlbc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"dlbc_tcga_pan_can_atlas_2018_gistic","dlbc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"dlbc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","dlbc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"dlbc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","dlbc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"dlbc_tcga_pan_can_atlas_2018_log2CNA","dlbc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"dlbc_tcga_pan_can_atlas_2018_mutations","dlbc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (MSK-IMPACT)","Putative copy-number calls derived from IMPACT data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"egc_msk_2017_cna","egc_msk_2017"
"MUTATION_EXTENDED","MAF","Mutations","IMPACT sequencing of tumor/normal samples",true,"egc_msk_2017_mutations","egc_msk_2017"
"MUTATION_EXTENDED","MAF","Whole-exome sequencing","Mutations from WXS cohort for 78 cases of Gastric Adencocarcinoma",true,"egc_tmucih_2015_mutations","egc_tmucih_2015"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 149 tumor/normal pairs.",true,"esca_broad_mutations","esca_broad"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"esca_tcga_rppa","esca_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"esca_tcga_rppa_Zscores","esca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 184 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"esca_tcga_gistic","esca_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 196 esca cases (RNA Seq V2 RSEM).",false,"esca_tcga_rna_seq_v2_mrna","esca_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"esca_tcga_rna_seq_v2_mrna_median_Zscores","esca_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"esca_tcga_linear_CNA","esca_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 202 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"esca_tcga_methylation_hm450","esca_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: ESCA/20160128/gdac.broadinstitute.org_ESCA.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"esca_tcga_mutations","esca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"esca_tcga_pan_can_atlas_2018_gistic","esca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"esca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","esca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"esca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","esca_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"esca_tcga_pan_can_atlas_2018_log2CNA","esca_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"esca_tcga_pan_can_atlas_2018_mutations","esca_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from genome or exome sequencing of 88 tumor/normal pairs.",true,"escc_icgc_mutations","escc_icgc"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 20 esophageal squamous cell carcinoma(escc) patients and targeted deep sequencing of 119 escc patients.",true,"escc_ucla_2014_mutations","escc_ucla_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 92 pediatric Ewing Sarcoma tumors and 11 cell lines.",true,"es_dfarber_broad_2014_mutations","es_dfarber_broad_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-genome sequencing of 112 Ewing sarcoma samples and matched germ line DNA.",true,"es_iocurie_2014_mutations","es_iocurie_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 32 gallbladder carcinoma tumors with paired normals.",true,"gbc_shanghai_2014_mutations","gbc_shanghai_2014"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"gbm_tcga_rppa","gbm_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"gbm_tcga_rppa_Zscores","gbm_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 577 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gbm_tcga_gistic","gbm_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (U133 microarray only)","mRNA expression data from the Affymetrix U133 microarray.",false,"gbm_tcga_mrna_U133","gbm_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (U133 microarray only)","mRNA z-Scores  (U133 microarray only) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"gbm_tcga_mrna_U133_Zscores","gbm_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 411 gbm cases (Agilent microarray).",false,"gbm_tcga_mrna","gbm_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"gbm_tcga_mrna_median_Zscores","gbm_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 171 gbm cases (RNA Seq V2 RSEM).",false,"gbm_tcga_rna_seq_v2_mrna","gbm_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"gbm_tcga_rna_seq_v2_mrna_median_Zscores","gbm_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"gbm_tcga_linear_CNA","gbm_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 285 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"gbm_tcga_methylation_hm27","gbm_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 155 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"gbm_tcga_methylation_hm450","gbm_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: GBM/20160128/gdac.broadinstitute.org_GBM.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"gbm_tcga_mutations","gbm_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gbm_tcga_pan_can_atlas_2018_gistic","gbm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"gbm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","gbm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"gbm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","gbm_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"gbm_tcga_pan_can_atlas_2018_log2CNA","gbm_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"gbm_tcga_pan_can_atlas_2018_mutations","gbm_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (RAE, 203 cases)","Putative copy-number calls for all genes in 203 GBM cases. Copy number calls were determined from the Agilent 244k platform using the RAE algorithm by Barry Taylor @ MSKCC. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gbm_tcga_pub_cna_rae","gbm_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (Consensus, GBM Pathways, 206 cases)","Putative copy-number calls for genes implicated in glioblastoma (206 cases). These calls were used for the pathway analysis in the initial TCGA manuscript, and they are the consensus of a combination of the Agilent 244k and Affymetrix SNP6 platforms and three different methods (RAE, GISTIC, GTS). Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gbm_tcga_pub_cna_consensus","gbm_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression","mRNA expression levels for 18,698 genes in 503 GBM cases using integrated values from the Affymetrix U133, Affymetrix Exon, and Agilent Platforms.",false,"gbm_tcga_pub_mrna","gbm_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","18,698 genes in 503 GBM cases using median expression values from the Affymetrix U133, Affymetrix Exon, and Agilent Platforms. z-Scores are computed relative to the expression distribution of each gene in tumors that are diploid for this gene.",true,"gbm_tcga_pub_mrna_median_Zscores","gbm_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation","Methylation beta-values (Infinium HumanMethylation27 platform). For genes with multiple methylation probes, the probe most negatively correlated with expression is used.",false,"gbm_tcga_pub_methylation_hm27","gbm_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data for ~1200 sequenced genes (Phases I/II of the TCGA glioblastoma project).",true,"gbm_tcga_pub_mutations","gbm_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","expression levels for microRNAs.",false,"gbm_tcga_pub_mirna","gbm_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"gbm_tcga_pub_mirna_median_Zscores","gbm_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",true,"gbm_tcga_pub_mrna_merged_median_Zscores","gbm_tcga_pub"
"PROTEIN_LEVEL","CONTINUOUS","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"gbm_tcga_pub2013_rppa","gbm_tcga_pub2013"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"gbm_tcga_pub2013_rppa_Zscores","gbm_tcga_pub2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 563 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gbm_tcga_pub2013_gistic","gbm_tcga_pub2013"
"MRNA_EXPRESSION","","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 154 GBM cases (RNA Seq V2 RSEM).",false,"gbm_tcga_pub2013_rna_seq_v2_mrna","gbm_tcga_pub2013"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"gbm_tcga_pub2013_rna_seq_v2_mrna_median_Zscores","gbm_tcga_pub2013"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"gbm_tcga_pub2013_linear_CNA","gbm_tcga_pub2013"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing of 291 tumors.",true,"gbm_tcga_pub2013_mutations","gbm_tcga_pub2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"gct_msk_2016_gistic","gct_msk_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"gct_msk_2016_mutations","gct_msk_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing(WXS) of 243 liver tumors identified mutational signatures associated with specific risk factors.",true,"hcc_inserm_fr_2015_mutations","hcc_inserm_fr_2015"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (IMPACT341)","Putative copy-number calls derived from IMPACT341 data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"hcc_msk_venturaa_2018_cna","hcc_msk_venturaa_2018"
"MUTATION_EXTENDED","MAF","Mutations","IMPACT341 sequencing of tumor/normal samples",true,"hcc_msk_venturaa_2018_mutations","hcc_msk_venturaa_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"hnc_mskcc_2016_gistic","hnc_mskcc_2016"
"MUTATION_EXTENDED","MAF","Mutations","IMPACT sequencing of tumor/normal samples",true,"hnc_mskcc_2016_mutations","hnc_mskcc_2016"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 74 tumor/normal pairs.",true,"hnsc_broad_mutations","hnsc_broad"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 32 tumor/normal pairs.",true,"hnsc_jhu_mutations","hnsc_jhu"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 40 tumor/normal pairs.",true,"hnsc_mdanderson_2013_mutations","hnsc_mdanderson_2013"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"hnsc_tcga_rppa","hnsc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"hnsc_tcga_rppa_Zscores","hnsc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 522 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"hnsc_tcga_gistic","hnsc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 566 hnsc cases (RNA Seq V2 RSEM).",false,"hnsc_tcga_rna_seq_v2_mrna","hnsc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"hnsc_tcga_rna_seq_v2_mrna_median_Zscores","hnsc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"hnsc_tcga_linear_CNA","hnsc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 580 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"hnsc_tcga_methylation_hm450","hnsc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: HNSC/20160128/gdac.broadinstitute.org_HNSC.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"hnsc_tcga_mutations","hnsc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"hnsc_tcga_pan_can_atlas_2018_gistic","hnsc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"hnsc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","hnsc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"hnsc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","hnsc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"hnsc_tcga_pan_can_atlas_2018_log2CNA","hnsc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"hnsc_tcga_pan_can_atlas_2018_mutations","hnsc_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"hnsc_tcga_pub_rppa","hnsc_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"hnsc_tcga_pub_rppa_Zscores","hnsc_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 306 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"hnsc_tcga_pub_gistic","hnsc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 303 hnsc cases (RNA Seq V2 RSEM).",false,"hnsc_tcga_pub_rna_seq_v2_mrna","hnsc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"hnsc_tcga_pub_rna_seq_v2_mrna_median_Zscores","hnsc_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"hnsc_tcga_pub_linear_CNA","hnsc_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 310 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"hnsc_tcga_pub_methylation_hm450","hnsc_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"hnsc_tcga_pub_mutations","hnsc_tcga_pub"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"kich_tcga_rppa","kich_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"kich_tcga_rppa_Zscores","kich_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 66 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kich_tcga_gistic","kich_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 91 chrcc cases (RNA Seq V2 RSEM).",false,"kich_tcga_rna_seq_v2_mrna","kich_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kich_tcga_rna_seq_v2_mrna_median_Zscores","kich_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"kich_tcga_linear_CNA","kich_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 66 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kich_tcga_methylation_hm450","kich_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: KICH/20160128/gdac.broadinstitute.org_KICH.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"kich_tcga_mutations","kich_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kich_tcga_pan_can_atlas_2018_gistic","kich_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"kich_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","kich_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"kich_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","kich_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"kich_tcga_pan_can_atlas_2018_log2CNA","kich_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"kich_tcga_pan_can_atlas_2018_mutations","kich_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 66 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kich_tcga_pub_gistic","kich_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 91 kich cases (RNA Seq V2 RSEM).",false,"kich_tcga_pub_rna_seq_v2_mrna","kich_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kich_tcga_pub_rna_seq_v2_mrna_median_Zscores","kich_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"kich_tcga_pub_linear_CNA","kich_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 66 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kich_tcga_pub_methylation_hm450","kich_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. From the KICH AWG, March 2013.",true,"kich_tcga_pub_mutations","kich_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 100 tumor/normal pairs.",true,"kirc_bgi_mutations","kirc_bgi"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"kirc_tcga_rppa","kirc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"kirc_tcga_rppa_Zscores","kirc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 528 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kirc_tcga_gistic","kirc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 72 ccrcc cases (Agilent microarray).",false,"kirc_tcga_mrna","kirc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirc_tcga_mrna_median_Zscores","kirc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 606 ccrcc cases (RNA Seq V2 RSEM).",false,"kirc_tcga_rna_seq_v2_mrna","kirc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirc_tcga_rna_seq_v2_mrna_median_Zscores","kirc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"kirc_tcga_linear_CNA","kirc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 418 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kirc_tcga_methylation_hm27","kirc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 480 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kirc_tcga_methylation_hm450","kirc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: KIRC/20160128/gdac.broadinstitute.org_KIRC.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"kirc_tcga_mutations","kirc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kirc_tcga_pan_can_atlas_2018_gistic","kirc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"kirc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","kirc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"kirc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","kirc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"kirc_tcga_pan_can_atlas_2018_log2CNA","kirc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"kirc_tcga_pan_can_atlas_2018_mutations","kirc_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"kirc_tcga_pub_rppa","kirc_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"kirc_tcga_pub_rppa_Zscores","kirc_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 436 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kirc_tcga_pub_gistic","kirc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17190 genes in 72 kirc cases (Agilent microarray).",false,"kirc_tcga_pub_mrna","kirc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirc_tcga_pub_mrna_median_Zscores","kirc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 469 kirc cases (RNA Seq V2 RSEM).",false,"kirc_tcga_pub_rna_seq_v2_mrna","kirc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirc_tcga_pub_rna_seq_v2_mrna_median_Zscores","kirc_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number valuesdata_filename: data_linear_CNA.txt","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"kirc_tcga_pub_linear_CNA","kirc_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 219 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"kirc_tcga_pub_methylation_hm27","kirc_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"kirc_tcga_pub_mutations","kirc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","expression levels for microRNAs.",false,"kirc_tcga_pub_mirna","kirc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"kirc_tcga_pub_mirna_median_Zscores","kirc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",false,"kirc_tcga_pub_mrna_merged_median_Zscores","kirc_tcga_pub"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"kirp_tcga_rppa","kirp_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"kirp_tcga_rppa_Zscores","kirp_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 288 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kirp_tcga_gistic","kirp_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 16 prcc cases (Agilent microarray).",false,"kirp_tcga_mrna","kirp_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirp_tcga_mrna_median_Zscores","kirp_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 323 prcc cases (RNA Seq V2 RSEM).",false,"kirp_tcga_rna_seq_v2_mrna","kirp_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"kirp_tcga_rna_seq_v2_mrna_median_Zscores","kirp_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"kirp_tcga_linear_CNA","kirp_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 21 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kirp_tcga_methylation_hm27","kirp_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 321 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"kirp_tcga_methylation_hm450","kirp_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: KIRP/20160128/gdac.broadinstitute.org_KIRP.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"kirp_tcga_mutations","kirp_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"kirp_tcga_pan_can_atlas_2018_gistic","kirp_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"kirp_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","kirp_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"kirp_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","kirp_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"kirp_tcga_pan_can_atlas_2018_log2CNA","kirp_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"kirp_tcga_pan_can_atlas_2018_mutations","kirp_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 191 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"laml_tcga_gistic","laml_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq RPKM)","Expression levels for 20443 genes in 179 aml cases (RNA Seq RPKM).",false,"laml_tcga_rna_seq_mrna","laml_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 173 aml cases (RNA Seq V2 RSEM).",false,"laml_tcga_rna_seq_v2_mrna","laml_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"laml_tcga_rna_seq_v2_mrna_median_Zscores","laml_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"laml_tcga_linear_CNA","laml_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 194 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"laml_tcga_methylation_hm27","laml_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 194 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"laml_tcga_methylation_hm450","laml_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: LAML/20160128/gdac.broadinstitute.org_LAML.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"laml_tcga_mutations","laml_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"laml_tcga_pan_can_atlas_2018_gistic","laml_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"laml_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","laml_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"laml_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","laml_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"laml_tcga_pan_can_atlas_2018_log2CNA","laml_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"laml_tcga_pan_can_atlas_2018_mutations","laml_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"laml_tcga_pub_gistic","laml_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels from RNA sequecing (RNA Seq V2 RSEM).",false,"laml_tcga_pub_rna_seq_v2_mrna","laml_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"laml_tcga_pub_rna_seq_v2_mrna_median_Zscores","laml_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"laml_tcga_pub_linear_CNA","laml_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values. For genes with multiple methylation probes, the probe least correlated with expression.",false,"laml_tcga_pub_methylation_hm27","laml_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values. For genes with multiple methylation probes, the probe least correlated with expression.",false,"laml_tcga_pub_methylation_hm450","laml_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome or genome sequencing.",true,"laml_tcga_pub_mutations","laml_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 159 tumor/normal pairs.",true,"lcll_broad_2013_mutations","lcll_broad_2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 563 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lgggbm_tcga_pub_gistic","lgggbm_tcga_pub"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"lgggbm_tcga_pub_log2CNA","lgggbm_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing of 291 tumors.",true,"lgggbm_tcga_pub_mutations","lgggbm_tcga_pub"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"lgg_tcga_rppa","lgg_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"lgg_tcga_rppa_Zscores","lgg_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 513 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lgg_tcga_gistic","lgg_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 27 difg cases (Agilent microarray).",false,"lgg_tcga_mrna","lgg_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lgg_tcga_mrna_median_Zscores","lgg_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 530 difg cases (RNA Seq V2 RSEM).",false,"lgg_tcga_rna_seq_v2_mrna","lgg_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lgg_tcga_rna_seq_v2_mrna_median_Zscores","lgg_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"lgg_tcga_linear_CNA","lgg_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 530 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"lgg_tcga_methylation_hm450","lgg_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: LGG/20160128/gdac.broadinstitute.org_LGG.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"lgg_tcga_mutations","lgg_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lgg_tcga_pan_can_atlas_2018_gistic","lgg_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"lgg_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","lgg_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"lgg_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","lgg_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"lgg_tcga_pan_can_atlas_2018_log2CNA","lgg_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"lgg_tcga_pan_can_atlas_2018_mutations","lgg_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 23 grade II glioma patients.",true,"lgg_ucsf_2014_mutations","lgg_ucsf_2014"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing(WXS) of 46 liver tumor and corresponding nontumor DNA.",true,"liad_inserm_fr_2014_mutations","liad_inserm_fr_2014"
"COPY_NUMBER_ALTERATION","","Putative copy-number alterations from SNP-FASST2","Putative copy-number calls on 231 cases determined using SNP-FASST2. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lihc_amc_prv_SNP-FASST2","lihc_amc_prv"
"MUTATION_EXTENDED","","Mutations","Mutation data from whole exome sequencing.",true,"lihc_amc_prv_mutations","lihc_amc_prv"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing of 27 tumor/normal pairs.",true,"lihc_riken_mutations","lihc_riken"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 370 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lihc_tcga_gistic","lihc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 423 hcc cases (RNA Seq V2 RSEM).",false,"lihc_tcga_rna_seq_v2_mrna","lihc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lihc_tcga_rna_seq_v2_mrna_median_Zscores","lihc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"lihc_tcga_linear_CNA","lihc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 429 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"lihc_tcga_methylation_hm450","lihc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: LIHC/20160128/gdac.broadinstitute.org_LIHC.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"lihc_tcga_mutations","lihc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lihc_tcga_pan_can_atlas_2018_gistic","lihc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"lihc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","lihc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"lihc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","lihc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"lihc_tcga_pan_can_atlas_2018_log2CNA","lihc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"lihc_tcga_pan_can_atlas_2018_mutations","lihc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls in 388 samples. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"luad_broad_cna","luad_broad"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 183 tumor/normal pairs.",true,"luad_broad_mutations","luad_broad"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from 34 lung exomes.",true,"luad_mskcc_2015_mutations","luad_mskcc_2015"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"luad_tcga_rppa","luad_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"luad_tcga_rppa_Zscores","luad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 516 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"luad_tcga_gistic","luad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 32 luad cases (Agilent microarray).",false,"luad_tcga_mrna","luad_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"luad_tcga_mrna_median_Zscores","luad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 576 luad cases (RNA Seq V2 RSEM).",false,"luad_tcga_rna_seq_v2_mrna","luad_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"luad_tcga_rna_seq_v2_mrna_median_Zscores","luad_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"luad_tcga_linear_CNA","luad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 150 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"luad_tcga_methylation_hm27","luad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 492 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"luad_tcga_methylation_hm450","luad_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: LUAD/20160128/gdac.broadinstitute.org_LUAD.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"luad_tcga_mutations","luad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"luad_tcga_pan_can_atlas_2018_gistic","luad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"luad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","luad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"luad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","luad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"luad_tcga_pan_can_atlas_2018_log2CNA","luad_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"luad_tcga_pan_can_atlas_2018_mutations","luad_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"luad_tcga_pub_rppa","luad_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"luad_tcga_pub_rppa_Zscores","luad_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 230 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"luad_tcga_pub_gistic","luad_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17235 genes in 32 luad cases (Agilent microarray).",false,"luad_tcga_pub_mrna","luad_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"luad_tcga_pub_mrna_median_Zscores","luad_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 230 luad cases (RNA Seq V2 RSEM).",false,"luad_tcga_pub_rna_seq_v2_mrna","luad_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"luad_tcga_pub_rna_seq_v2_mrna_median_Zscores","luad_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"luad_tcga_pub_linear_CNA","luad_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 126 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"luad_tcga_pub_methylation_hm27","luad_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 435 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"luad_tcga_pub_methylation_hm450","luad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"luad_tcga_pub_mutations","luad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from targeted sequencing of 163 tumor/normal pairs.",true,"luad_tsp_mutations","luad_tsp"
"COPY_NUMBER_ALTERATION","DISCRETE","copy-number alterations","Discrete copy-number data from IMPACT",true,"lung_msk_2017_cna","lung_msk_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from IMPACT testing",true,"lung_msk_2017_mutations","lung_msk_2017"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"lusc_tcga_rppa","lusc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"lusc_tcga_rppa_Zscores","lusc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 501 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lusc_tcga_gistic","lusc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (U133 microarray only)","mRNA expression data from the Affymetrix U133 microarray.",false,"lusc_tcga_mrna_U133","lusc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (U133 microarray only)","mRNA z-Scores  (U133 microarray only) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lusc_tcga_mrna_U133_Zscores","lusc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 154 lusc cases (Agilent microarray).",false,"lusc_tcga_mrna","lusc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lusc_tcga_mrna_median_Zscores","lusc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 552 lusc cases (RNA Seq V2 RSEM).",false,"lusc_tcga_rna_seq_v2_mrna","lusc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lusc_tcga_rna_seq_v2_mrna_median_Zscores","lusc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"lusc_tcga_linear_CNA","lusc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 160 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"lusc_tcga_methylation_hm27","lusc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 412 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"lusc_tcga_methylation_hm450","lusc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: LUSC/20160128/gdac.broadinstitute.org_LUSC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"lusc_tcga_mutations","lusc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lusc_tcga_pan_can_atlas_2018_gistic","lusc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"lusc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","lusc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"lusc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","lusc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"lusc_tcga_pan_can_atlas_2018_log2CNA","lusc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"lusc_tcga_pan_can_atlas_2018_mutations","lusc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"lusc_tcga_pub_gistic","lusc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq RPKM)","Expression levels (RNA Seq RPKM).",false,"lusc_tcga_pub_rna_seq_mrna","lusc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lusc_tcga_pub_rna_seq_mrna_median_Zscores","lusc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels (Agilent microarray).",false,"lusc_tcga_pub_mrna","lusc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"lusc_tcga_pub_mrna_median_Zscores","lusc_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"lusc_tcga_pub_linear_CNA","lusc_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (HM27 platform). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"lusc_tcga_pub_methylation_hm27","lusc_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"lusc_tcga_pub_mutations","lusc_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"lusc_tcga_pub_mirna","lusc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"lusc_tcga_pub_mirna_median_Zscores","lusc_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",false,"lusc_tcga_pub_mrna_merged_median_Zscores","lusc_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 92 tumor/normal pairs.",true,"mbl_broad_2012_mutations","mbl_broad_2012"
"MUTATION_EXTENDED","MAF","Mutations","Exome sequencing of 125 tumor normal pairs.",true,"mbl_icgc_mutations","mbl_icgc"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing of 37 tumor/normal pairs.",true,"mbl_pcgp_mutations","mbl_pcgp"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-genome sequencing (WGS) of 46 recurrent medulloblastoma samples.",true,"mbl_sickkids_2016_mutations","mbl_sickkids_2016"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 29 tumors.",true,"mcl_idibips_2013_mutations","mcl_idibips_2013"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 29 tumor/normal pairs.",true,"mds_tokyo_2011_mutations","mds_tokyo_2011"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from tConut","Putative copy-number from tConut. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"mel_tsam_liang_2017_cna","mel_tsam_liang_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"mel_tsam_liang_2017_mutations","mel_tsam_liang_2017"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"meso_tcga_rppa","meso_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"meso_tcga_rppa_Zscores","meso_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 87 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"meso_tcga_gistic","meso_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 87 plmeso cases (RNA Seq V2 RSEM).",false,"meso_tcga_rna_seq_v2_mrna","meso_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"meso_tcga_rna_seq_v2_mrna_median_Zscores","meso_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"meso_tcga_linear_CNA","meso_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 87 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"meso_tcga_methylation_hm450","meso_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"meso_tcga_mutations","meso_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"meso_tcga_pan_can_atlas_2018_gistic","meso_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"meso_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","meso_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"meso_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","meso_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"meso_tcga_pan_can_atlas_2018_log2CNA","meso_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"meso_tcga_pan_can_atlas_2018_mutations","meso_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutations.",true,"mixed_allen_2018_mutations","mixed_allen_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"mixed_pipseq_2017_mutations","mixed_pipseq_2017"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 205 tumor/normal pairs.",true,"mm_broad_mutations","mm_broad"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"mpnst_mskcc_cna","mpnst_mskcc"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 15 tumor/normal pairs.",true,"mpnst_mskcc_mutations","mpnst_mskcc"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome sequencing.",true,"mrt_bcgsc_2016_mutations","mrt_bcgsc_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Copy Number Alterations (MSK-IMPACT)","Copy number alterations from targeted sequencing via MK-IMPACT on Illumina HiSeq sequencers.",true,"msk_impact_2017_cna","msk_impact_2017"
"MUTATION_EXTENDED","MAF","Mutations (MSK-IMPACT)","Targeted sequencing of various tumor types via MSK-IMPACT on Illumina HiSeq sequencers.",true,"msk_impact_2017_mutations","msk_impact_2017"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing of 87 tumor/normal pairs.",true,"nbl_amc_2012_mutations","nbl_amc_2012"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome and whole genome sequencing of 240 tumor/normal pairs.",true,"nbl_broad_2013_mutations","nbl_broad_2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 115 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"nbl_target_2018_pub_gistic","nbl_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA-Seq RPKM)","Expression levels for 24946 genes in 144 nbl cases (RNA-Seq RPKM).",false,"nbl_target_2018_pub_rna_seq_mrna","nbl_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"nbl_target_2018_pub_rna_seq_mrna_median_Zscores","nbl_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression (microarray)","mRNA expression levels (Affymetrix microarray)",false,"nbl_target_2018_pub_mirna_median_Zscores","nbl_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"nbl_target_2018_pub_mrna_median_Zscores","nbl_target_2018_pub"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from whole genome or whole exome sequencing on 313 samples.",true,"nbl_target_2018_pub_mutations","nbl_target_2018_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-genome sequencing of 56 neuroblastomas and matched normal controls.",true,"nbl_ucologne_2015_mutations","nbl_ucologne_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 139 non-clear cell renal carcinoma samples.",true,"nccrcc_genentech_2014_mutations","nccrcc_genentech_2014"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations adjusted by ploidy and purity with CLONET","Putative copy-number alterations adjusted by ploidy and purity with CLONET. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"nepc_wcm_2016_cna","nepc_wcm_2016"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression","Expression levels.",false,"nepc_wcm_2016_mrna","nepc_wcm_2016"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number value","Log2 copy-number values for each gene obtained from CNVseeqer pipeline and adjusted by ploidy and purity with CLONET",false,"nepc_wcm_2016_log2CNA","nepc_wcm_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing",true,"nepc_wcm_2016_mutations","nepc_wcm_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome and whole genome sequencing of 14 NHL samples.",true,"nhl_bcgsc_2011_mutations","nhl_bcgsc_2011"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing.",true,"nhl_bcgsc_2013_mutations","nhl_bcgsc_2013"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from Whole genome sequencing on 56 NPC samples.",true,"npc_nusingapore_mutations","npc_nusingapore"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Copy Number data",true,"nsclc_pd1_msk_2018_cna","nsclc_pd1_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from next-gen sequencing.",true,"nsclc_pd1_msk_2018_mutations","nsclc_pd1_msk_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"nsclc_tcga_broad_2016_cna","nsclc_tcga_broad_2016"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status.",true,"nsclc_tcga_broad_2016_mutations","nsclc_tcga_broad_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from targeted ngs sequencing.",true,"nsclc_unito_2016_mutations","nsclc_unito_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"odg_msk_2017_gistic","odg_msk_2017"
"MUTATION_EXTENDED","MAF","Mutations","Sequencing of samples",true,"odg_msk_2017_mutations","odg_msk_2017"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"ov_tcga_rppa","ov_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"ov_tcga_rppa_Zscores","ov_tcga"
"PROTEIN_LEVEL","CONTINUOUS","Protein levels (mass spectrometry by CPTAC)","Protein levels measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",false,"ov_tcga_protein_quantification","ov_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein level Z-scores (mass spectrometry by CPTAC)","Protein level Z-scores measured with mass spectrometry by the Clinical Proteomic Tumor Analysis Consortium (CPTAC)",true,"ov_tcga_protein_quantification_zscores","ov_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 579 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ov_tcga_gistic","ov_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (U133 microarray only)","mRNA expression data from the Affymetrix U133 microarray.",false,"ov_tcga_mrna_U133","ov_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (U133 microarray only)","mRNA z-Scores  (U133 microarray only) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ov_tcga_mrna_U133_Zscores","ov_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 561 hgsoc cases (Agilent microarray).",false,"ov_tcga_mrna","ov_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ov_tcga_mrna_median_Zscores","ov_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 307 hgsoc cases (RNA Seq V2 RSEM).",false,"ov_tcga_rna_seq_v2_mrna","ov_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ov_tcga_rna_seq_v2_mrna_median_Zscores","ov_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"ov_tcga_linear_CNA","ov_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 10 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"ov_tcga_methylation_hm450","ov_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: OV/20160128/gdac.broadinstitute.org_OV.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"ov_tcga_mutations","ov_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ov_tcga_pan_can_atlas_2018_gistic","ov_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ov_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ov_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"ov_tcga_pan_can_atlas_2018_log2CNA","ov_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"ov_tcga_pan_can_atlas_2018_mutations","ov_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (GISTIC)","Putative copy-number calls determined using Gistic2 on the MSKCC Agilent 1M data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ov_tcga_pub_gistic","ov_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (all genes)","mRNA expression values, median values from all three mRNA expression platforms.",false,"ov_tcga_pub_mrna","ov_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression Z-scores (all genes)","mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms.",true,"ov_tcga_pub_mrna_median_Zscores","ov_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"ov_tcga_pub_linear_CNA","ov_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation beta-values (HM27 platform). For genes with multiple methylation probes, the probe most negatively correlated with expression is used.",false,"ov_tcga_pub_methylation_hm27","ov_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations and BRCA1 and BRCA2 germline mutations from whole exome sequencing.",true,"ov_tcga_pub_mutations","ov_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","expression levels for microRNAs.",false,"ov_tcga_pub_mirna","ov_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",true,"ov_tcga_pub_mirna_median_Zscores","ov_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA/miRNA expression Z-scores (all genes)","mRNA and microRNA Z-scores merged: mRNA expression Z-scores compared to diploid tumors (diploid for each gene), median values from all three mRNA expression platforms; and miRNA z-Scores compared to all tumours.",true,"ov_tcga_pub_mrna_merged_median_Zscores","ov_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 23 surgically resected pancreatic carcinomas with acinar differentiation.",true,"paac_jhu_2014_mutations","paac_jhu_2014"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 99 tumor/normal pairs.",true,"paad_icgc_mutations","paad_icgc"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression","Expression levels",true,"paad_qcmg_uq_2016_rna_seq_v2_mrna_median_Zscores","paad_qcmg_uq_2016"
"MUTATION_EXTENDED","MAF","Mutations","Primary tumours (nâ??=â??342) and 41 patient-derived cell lines underwent whole genome sequencing (WGS) when tumour cellularity was >40% (nâ??=â??179), or deep-exome sequencing (nâ??=â??204) for samples with a cellularity of 12â??40%.",true,"paad_qcmg_uq_2016_mutations","paad_qcmg_uq_2016"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"paad_tcga_rppa","paad_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"paad_tcga_rppa_Zscores","paad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 184 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"paad_tcga_gistic","paad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 183 paad cases (RNA Seq V2 RSEM).",false,"paad_tcga_rna_seq_v2_mrna","paad_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"paad_tcga_rna_seq_v2_mrna_median_Zscores","paad_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"paad_tcga_linear_CNA","paad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 195 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"paad_tcga_methylation_hm450","paad_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: PAAD/20160128/gdac.broadinstitute.org_PAAD.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"paad_tcga_mutations","paad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"paad_tcga_pan_can_atlas_2018_gistic","paad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"paad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","paad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"paad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","paad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"paad_tcga_pan_can_atlas_2018_log2CNA","paad_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"paad_tcga_pan_can_atlas_2018_mutations","paad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"paad_utsw_2015_gistic","paad_utsw_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 109 pancreatic ductal adenocarcinoma (PDA) with paired normals.",true,"paad_utsw_2015_mutations","paad_utsw_2015"
"MUTATION_EXTENDED","MAF","Mutations","Whole-exome sequencing of major neoplastic cyst types of the pancreas: 8 serous cystadenomas (SCAs), 8 intraductal papillary mucinous neoplasms (IPMNs), 8 mucinous cystic neoplasms (MCNs), and 8 solid pseudopapillary neoplasms (SPNs).",true,"pact_jhu_2011_mutations","pact_jhu_2011"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome sequencing.",true,"panet_arcnet_2017_mutations","panet_arcnet_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 10 pancreatic neuroendocrine tumors.",true,"panet_jhu_2011_mutations","panet_jhu_2011"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 10 functional pancreatic neuroendocrine tumors.",true,"panet_shanghai_2013_mutations","panet_shanghai_2013"
"MUTATION_EXTENDED","MAF","Mutations","Mutation profile by Deep sequencing was carried out with Illumina HiSeq 2000 instruments",true,"past_dkfz_heidelberg_2013_mutations","past_dkfz_heidelberg_2013"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 19 immunocompetent primary central nervous system lymphoma(PCNSL) samples.",true,"pcnsl_mayo_2015_mutations","pcnsl_mayo_2015"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"pcpg_tcga_rppa","pcpg_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"pcpg_tcga_rppa_Zscores","pcpg_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 162 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"pcpg_tcga_gistic","pcpg_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 187 mnet cases (RNA Seq V2 RSEM).",false,"pcpg_tcga_rna_seq_v2_mrna","pcpg_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"pcpg_tcga_rna_seq_v2_mrna_median_Zscores","pcpg_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"pcpg_tcga_linear_CNA","pcpg_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 187 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"pcpg_tcga_methylation_hm450","pcpg_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: PCPG/20160128/gdac.broadinstitute.org_PCPG.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"pcpg_tcga_mutations","pcpg_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"pcpg_tcga_pan_can_atlas_2018_gistic","pcpg_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"pcpg_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","pcpg_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"pcpg_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","pcpg_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"pcpg_tcga_pan_can_atlas_2018_log2CNA","pcpg_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"pcpg_tcga_pan_can_atlas_2018_mutations","pcpg_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"pediatric_dkfz_2017_mutations","pediatric_dkfz_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole-exome sequencing of 22 malignant pleural mesotheliomas(PLMESO) and matched blood samples.",true,"plmeso_nyu_2015_mutations","plmeso_nyu_2015"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_broad_cna","prad_broad"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression","mRNA expression values from 31 samples",false,"prad_broad_mrna","prad_broad"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"prad_broad_mrna_median_Zscores","prad_broad"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 112 tumor/normal pairs.",true,"prad_broad_mutations","prad_broad"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_broad_2013_cna","prad_broad_2013"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene.",false,"prad_broad_2013_log2CNA","prad_broad_2013"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole-genome sequencing of 57 tumor/normal pairs.",true,"prad_broad_2013_mutations","prad_broad_2013"
"MUTATION_EXTENDED","MAF","Mutations","Genomic profiling of 477 prostate samples from CPC-GENE and public data sets, including TCGA-PRAD.",true,"prad_cpcg_2017_mutations","prad_cpcg_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from CNVkit.","Putative copy-number calls determined using CNVkit. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_eururol_2017_cna","prad_eururol_2017"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome sequencing.",true,"prad_eururol_2017_mutations","prad_eururol_2017"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (FPKM)","mRNA expression from capture (RNA Seq FPKM).",false,"prad_eururol_2017_mrna_seq_fpkm","prad_eururol_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_fhcrc_cna","prad_fhcrc"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression","Expression levelsN",false,"prad_fhcrc_rna_seq_mrna","prad_fhcrc"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"prad_fhcrc_mrna_median_Zscores","prad_fhcrc"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"prad_fhcrc_log2CNA","prad_fhcrc"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"prad_fhcrc_mutations","prad_fhcrc"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_mich_cna","prad_mich"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 61 tumor/normal pairs.",true,"prad_mich_mutations","prad_mich"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (RAE)","Putative copy-number calls of protein-coding and microRNA genes, determined using the RAE algorithm (Taylor et al. PLoS One. 2008). Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = no change; 1 = gain; 2 = high level amplification",true,"prad_mskcc_cna","prad_mskcc"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression","log2 whole transcript mRNA expression values (Affymetrix Human Exon 1.0 ST arrays)",false,"prad_mskcc_mrna_median_Zscores","prad_mskcc"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Z-Scores vs Normals","mRNA Z-Scores compared to expression in normal prostate samples",true,"prad_mskcc_mrna_zbynorm","prad_mskcc"
"MUTATION_EXTENDED","MAF","Mutations","Validated somatic mutations, known oncogenic, and cell line mutations (135 sequenced genes)",true,"prad_mskcc_mutations","prad_mskcc"
"MRNA_EXPRESSION","DISCRETE","mRNA Expression Outliers","mRNA expression outliers compared to normal prostate (-1 = underexpressed, 1 = overexpressed)",true,"prad_mskcc_mrna_outliers","prad_mskcc"
"COPY_NUMBER_ALTERATION","DISCRETE","COPY_NUMBER_ALTERATION","Discrete copy-number calls from the RAE algorithm. -2 = putative homozygous deletion; -1 = putative hemizygous deletion; 0 = copy-neutral; 1 = low-level gain; 2 = high-level amplification.",true,"prad_mskcc_2014_cna","prad_mskcc_2014"
"COPY_NUMBER_ALTERATION","DISCRETE","MSK-IMPACT Clinical Sequencing Cohort (MSKCC)","Targeted sequencing of clinical cases via MSK-IMPACT for prostate cancer.Values: -2 = homozygous deletion; 2 = high level amplification.",true,"prad_mskcc_2017_cna","prad_mskcc_2017"
"MUTATION_EXTENDED","MAF","Mutations (MSK-IMPACT)","Targeted sequencing of various tumor types via MSK-IMPACT on Illumina HiSeq sequencers for prostate cancer cases.",true,"prad_mskcc_2017_mutations","prad_mskcc_2017"
"MRNA_EXPRESSION","","mRNA expression (RNA Seq FPKM)","mRNA expression (RNA Seq FPKM)",false,"prad_mskcc_cheny1_organoids_2014_rna_seq_rna","prad_mskcc_cheny1_organoids_2014"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing.",true,"prad_mskcc_cheny1_organoids_2014_mutations","prad_mskcc_cheny1_organoids_2014"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.data_filename: data_CNA.txt",true,"prad_p1000_cna","prad_p1000"
"MUTATION_EXTENDED","MAF","Mutations from CMO WES dataset","Mutations from Pan-Prostate P1000",true,"prad_p1000_mutations","prad_p1000"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls determined using GISTIC 2.0 and, in some cases, manual review. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_su2c_2015_gistic","prad_su2c_2015"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from whole exome sequencing).",false,"prad_su2c_2015_log2CNA","prad_su2c_2015"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"prad_su2c_2015_mutations","prad_su2c_2015"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"prad_tcga_rppa","prad_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"prad_tcga_rppa_Zscores","prad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 492 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_tcga_gistic","prad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 550 prad cases (RNA Seq V2 RSEM).",false,"prad_tcga_rna_seq_v2_mrna","prad_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"prad_tcga_rna_seq_v2_mrna_median_Zscores","prad_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"prad_tcga_linear_CNA","prad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 549 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"prad_tcga_methylation_hm450","prad_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: PRAD/20160128/gdac.broadinstitute.org_PRAD.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"prad_tcga_mutations","prad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_tcga_pan_can_atlas_2018_gistic","prad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"prad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","prad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"prad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","prad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"prad_tcga_pan_can_atlas_2018_log2CNA","prad_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"prad_tcga_pan_can_atlas_2018_mutations","prad_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"prad_tcga_pub_rppa","prad_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"prad_tcga_pub_rppa_Zscores","prad_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls determined using GISTIC 2.0 and, in some cases, manual review. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"prad_tcga_pub_gistic","prad_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","mRNA expression levels (RSEM UNC).",false,"prad_tcga_pub_rna_seq_v2_mrna","prad_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"prad_tcga_pub_rna_seq_v2_mrna_median_Zscores","prad_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"prad_tcga_pub_linear_CNA","prad_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 333 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"prad_tcga_pub_methylation_hm450","prad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"prad_tcga_pub_mutations","prad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from WGS and/or WXS of 43 rhabdomyosarcoma samples.",true,"rms_nih_2014_mutations","rms_nih_2014"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA-Seq RPKM)","Expression levels for 26136 genes in 47 RT cases (RNA-Seq RPKM).",false,"rt_target_2018_pub_rna_seq_mrna","rt_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors.",true,"rt_target_2018_pub_rna_seq_mrna_median_Zscores","rt_target_2018_pub"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from whole genome sequencing of 48 samples",true,"rt_target_2018_pub_mutations","rt_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"rt_target_2018_pub_mirna","rt_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","microRNA expression Z-scores","microRNA expression Z-scores compared to all tumors.",false,"rt_target_2018_pub_mirna_median_Zscores","rt_target_2018_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (RAE)","Putative copy-number calls, determined using the RAE algorithm from Affymetrix 250K SNP array data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"sarc_mskcc_cna","sarc_mskcc"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression","mRNA expression data (Affymetrix U133A).",false,"sarc_mskcc_mrna","sarc_mskcc"
"MRNA_EXPRESSION","Z-SCORE","mRNA Z-scores vs normal fat","mRNA Z-scores compared to expression in normal fat samples. Only for subtypes arising from an adipose precursor cell (DDLPS, PLEO, MYXOID).",true,"sarc_mskcc_mrna_znormal","sarc_mskcc"
"MUTATION_EXTENDED","MAF","Mutations","Validated somatic mutations (Sanger biochemistry, 722 protein-coding genes and microRNAs).",true,"sarc_mskcc_mutations","sarc_mskcc"
"MRNA_EXPRESSION","DISCRETE","mRNA outliers","mRNA expression outliers compared to normal fat (-1 = underexpressed, 1 = overexpressed). Only for subtypes arising from an adipose precursor cell (DDLPS, PLEO, MYXOID).",true,"sarc_mskcc_mrna_outlier","sarc_mskcc"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"sarc_tcga_rppa","sarc_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"sarc_tcga_rppa_Zscores","sarc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 257 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"sarc_tcga_gistic","sarc_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 265 soft_tissue cases (RNA Seq V2 RSEM).",false,"sarc_tcga_rna_seq_v2_mrna","sarc_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"sarc_tcga_rna_seq_v2_mrna_median_Zscores","sarc_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"sarc_tcga_linear_CNA","sarc_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 269 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"sarc_tcga_methylation_hm450","sarc_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: SARC/20160128/gdac.broadinstitute.org_SARC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"sarc_tcga_mutations","sarc_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"sarc_tcga_pan_can_atlas_2018_gistic","sarc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"sarc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","sarc_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"sarc_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","sarc_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"sarc_tcga_pan_can_atlas_2018_log2CNA","sarc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"sarc_tcga_pan_can_atlas_2018_mutations","sarc_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from targeted sequencing of 12 SCCO samples.",true,"scco_mskcc_mutations","scco_mskcc"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations",true,"sclc_cancercell_gardner_2017_mutations","sclc_cancercell_gardner_2017"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 29 tumor/normal pairs.",true,"sclc_clcgp_mutations","sclc_clcgp"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 42 tumor/normal pairs.",true,"sclc_jhu_mutations","sclc_jhu"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole genome sequencing of 110 human small cell lung cancer(SCLC) specimens.",true,"sclc_ucologne_2015_mutations","sclc_ucologne_2015"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 121 tumor/normal pairs.",true,"skcm_broad_mutations","skcm_broad"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 121 tumor/normal pairs.",true,"skcm_broad_brafresist_2012_mutations","skcm_broad_brafresist_2012"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing of 25 metastatic melanomas.",true,"skcm_broad_dfarber_mutations","skcm_broad_dfarber"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"skcm_tcga_rppa","skcm_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"skcm_tcga_rppa_Zscores","skcm_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 367 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"skcm_tcga_gistic","skcm_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 473 skcm cases (RNA Seq V2 RSEM).",false,"skcm_tcga_rna_seq_v2_mrna","skcm_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"skcm_tcga_rna_seq_v2_mrna_median_Zscores","skcm_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"skcm_tcga_linear_CNA","skcm_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 475 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"skcm_tcga_methylation_hm450","skcm_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: SKCM/20160128/gdac.broadinstitute.org_SKCM.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"skcm_tcga_mutations","skcm_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"skcm_tcga_pan_can_atlas_2018_gistic","skcm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"skcm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","skcm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"skcm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","skcm_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"skcm_tcga_pan_can_atlas_2018_log2CNA","skcm_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"skcm_tcga_pan_can_atlas_2018_mutations","skcm_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation profile by WES",true,"skcm_ucla_2016_mutations","skcm_ucla_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"skcm_vanderbilt_mskcc_2015_gistic","skcm_vanderbilt_mskcc_2015"
"MUTATION_EXTENDED","MAF","Mutations","BRAF mutant melanoma: MSKCC (pre-treatment)-Vanderbilt (MSKCC 2015)",true,"skcm_vanderbilt_mskcc_2015_mutations","skcm_vanderbilt_mskcc_2015"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 91 tumor/normal pairs.",true,"skcm_yale_mutations","skcm_yale"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from whole genome sequencing of 100 tumor/normal pairs.",true,"stad_pfizer_uhongkong_mutations","stad_pfizer_uhongkong"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"stad_tcga_rppa","stad_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"stad_tcga_rppa_Zscores","stad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 441 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"stad_tcga_gistic","stad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq RPKM)","Expression levels for 29699 genes in 36 stad cases (RNA Seq RPKM).",false,"stad_tcga_rna_seq_mrna","stad_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 450 stad cases (RNA Seq V2 RSEM).",false,"stad_tcga_rna_seq_v2_mrna","stad_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"stad_tcga_rna_seq_v2_mrna_median_Zscores","stad_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"stad_tcga_linear_CNA","stad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 73 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"stad_tcga_methylation_hm27","stad_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 397 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"stad_tcga_methylation_hm450","stad_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: STAD/20160128/gdac.broadinstitute.org_STAD.Mutation_Packager_Raw_Calls.Level_3.2016012800.0.0.tar.gz.",true,"stad_tcga_mutations","stad_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"stad_tcga_pan_can_atlas_2018_gistic","stad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"stad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","stad_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"stad_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","stad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"stad_tcga_pan_can_atlas_2018_log2CNA","stad_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"stad_tcga_pan_can_atlas_2018_mutations","stad_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 293 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"stad_tcga_pub_gistic","stad_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","mRNA expression levels (BCGSC).",false,"stad_tcga_pub_rna_seq_v2_mrna","stad_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"stad_tcga_pub_rna_seq_v2_mrna_median_Zscores","stad_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"stad_tcga_pub_linear_CNA","stad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"stad_tcga_pub_mutations","stad_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 22 gastric samples.",true,"stad_uhongkong_mutations","stad_uhongkong"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutations from exome sequencing of 30 tumor/normal pairs.",true,"stad_utokyo_mutations","stad_utokyo"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"stes_tcga_pub_gistic","stes_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"stes_tcga_pub_mutations","stes_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Copy-number alterations from sequencing data","Copy-number from MSK-IMPACT and FACETS. Values: -2 = homozygous deletion; 0 = neutral / no change; 2 = high level amplification.",true,"summit_2018_cna","summit_2018"
"MUTATION_EXTENDED","MAF","Mutation data from MSK-IMPACT sequencing","Mutations",true,"summit_2018_mutations","summit_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 28 thymic epithelial tumors patients.",true,"tet_nci_2014_mutations","tet_nci_2014"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"tgct_tcga_rppa","tgct_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"tgct_tcga_rppa_Zscores","tgct_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 150 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"tgct_tcga_gistic","tgct_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 156 nsgct cases (RNA Seq V2 RSEM).",false,"tgct_tcga_rna_seq_v2_mrna","tgct_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"tgct_tcga_rna_seq_v2_mrna_median_Zscores","tgct_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"tgct_tcga_linear_CNA","tgct_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 156 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"tgct_tcga_methylation_hm450","tgct_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: TGCT/20160128/gdac.broadinstitute.org_TGCT.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"tgct_tcga_mutations","tgct_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"tgct_tcga_pan_can_atlas_2018_gistic","tgct_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"tgct_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","tgct_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"tgct_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","tgct_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"tgct_tcga_pan_can_atlas_2018_log2CNA","tgct_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"tgct_tcga_pan_can_atlas_2018_mutations","tgct_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"thca_tcga_rppa","thca_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"thca_tcga_rppa_Zscores","thca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 90 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thca_tcga_gistic","thca_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 79 acc cases (RNA Seq V2 RSEM).",false,"thca_tcga_rna_seq_v2_mrna","thca_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"thca_tcga_rna_seq_v2_mrna_median_Zscores","thca_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 80 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"thca_tcga_methylation_hm450","thca_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: THCA/20160128/gdac.broadinstitute.org_THCA.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"thca_tcga_mutations","thca_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thca_tcga_pan_can_atlas_2018_gistic","thca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"thca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","thca_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"thca_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","thca_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"thca_tcga_pan_can_atlas_2018_log2CNA","thca_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"thca_tcga_pan_can_atlas_2018_mutations","thca_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"thca_tcga_pub_rppa","thca_tcga_pub"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"thca_tcga_pub_rppa_Zscores","thca_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 496 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thca_tcga_pub_gistic","thca_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 486 thca cases (RNA Seq V2 RSEM).",false,"thca_tcga_pub_rna_seq_v2_mrna","thca_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"thca_tcga_pub_rna_seq_v2_mrna_median_Zscores","thca_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"thca_tcga_pub_linear_CNA","thca_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 504 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"thca_tcga_pub_methylation_hm450","thca_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"thca_tcga_pub_mutations","thca_tcga_pub"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"thym_tcga_rppa","thym_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"thym_tcga_rppa_Zscores","thym_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 123 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thym_tcga_gistic","thym_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 122 thym cases (RNA Seq V2 RSEM).",false,"thym_tcga_rna_seq_v2_mrna","thym_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"thym_tcga_rna_seq_v2_mrna_median_Zscores","thym_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"thym_tcga_linear_CNA","thym_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 126 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"thym_tcga_methylation_hm450","thym_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: THYM/20160128/gdac.broadinstitute.org_THYM.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"thym_tcga_mutations","thym_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thym_tcga_pan_can_atlas_2018_gistic","thym_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"thym_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","thym_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"thym_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","thym_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"thym_tcga_pan_can_atlas_2018_log2CNA","thym_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"thym_tcga_pan_can_atlas_2018_mutations","thym_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"thyroid_mskcc_2016_gistic","thyroid_mskcc_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from NG sequencing.",true,"thyroid_mskcc_2016_mutations","thyroid_mskcc_2016"
"MUTATION_EXTENDED","MAF","Mutations","Somatic mutation data from whole exome sequencing of 16 clear cell endometrial cancer samples.",true,"uccc_nih_2017_mutations","uccc_nih_2017"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations","Putative copy-number calls derived from IMPACT341 data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucec_msk_2018_cna","ucec_msk_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from MSK-IMPACT .",true,"ucec_msk_2018_mutations","ucec_msk_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"ucec_tcga_rppa","ucec_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"ucec_tcga_rppa_Zscores","ucec_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 539 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucec_tcga_gistic","ucec_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17155 genes in 54 ucec cases (Agilent microarray).",false,"ucec_tcga_mrna","ucec_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ucec_tcga_mrna_median_Zscores","ucec_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 201 ucec cases (RNA Seq V2 RSEM).",false,"ucec_tcga_rna_seq_v2_mrna","ucec_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ucec_tcga_rna_seq_v2_mrna_median_Zscores","ucec_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"ucec_tcga_linear_CNA","ucec_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 118 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"ucec_tcga_methylation_hm27","ucec_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 478 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"ucec_tcga_methylation_hm450","ucec_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: UCEC/20160128/gdac.broadinstitute.org_UCEC.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"ucec_tcga_mutations","ucec_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucec_tcga_pan_can_atlas_2018_gistic","ucec_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ucec_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"ucec_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ucec_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"ucec_tcga_pan_can_atlas_2018_log2CNA","ucec_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"ucec_tcga_pan_can_atlas_2018_mutations","ucec_tcga_pan_can_atlas_2018"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"ucec_tcga_pub_rppa","ucec_tcga_pub"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 363 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucec_tcga_pub_gistic","ucec_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","Expression levels for 17190 genes in 54 ucec cases (Agilent microarray).",false,"ucec_tcga_pub_mrna","ucec_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ucec_tcga_pub_mrna_median_Zscores","ucec_tcga_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 333 ucec cases (RNA Seq V2 RSEM).",false,"ucec_tcga_pub_rna_seq_v2_mrna","ucec_tcga_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ucec_tcga_pub_rna_seq_v2_mrna_median_Zscores","ucec_tcga_pub"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"ucec_tcga_pub_linear_CNA","ucec_tcga_pub"
"METHYLATION","CONTINUOUS","Methylation (HM27)","Methylation (HM27) beta-values for genes in 117 cases. For genes with multiple methylation probes, the probe least correlated with expression.",false,"ucec_tcga_pub_methylation_hm27","ucec_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing.",true,"ucec_tcga_pub_mutations","ucec_tcga_pub"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing of 22 uterine carcinosarcoma, or malignant mixed Mullerian tumor patients.",true,"ucs_jhu_2014_mutations","ucs_jhu_2014"
"PROTEIN_LEVEL","LOG2-VALUE","Protein expression (RPPA)","Protein expression measured by reverse-phase protein array",false,"ucs_tcga_rppa","ucs_tcga"
"PROTEIN_LEVEL","Z-SCORE","Protein expression Z-scores (RPPA)","Protein expression, measured by reverse-phase protein array, Z-scores",true,"ucs_tcga_rppa_Zscores","ucs_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 56 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucs_tcga_gistic","ucs_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 57 ucs cases (RNA Seq V2 RSEM).",false,"ucs_tcga_rna_seq_v2_mrna","ucs_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"ucs_tcga_rna_seq_v2_mrna_median_Zscores","ucs_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"ucs_tcga_linear_CNA","ucs_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 57 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"ucs_tcga_methylation_hm450","ucs_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: UCS/20160128/gdac.broadinstitute.org_UCS.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"ucs_tcga_mutations","ucs_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"ucs_tcga_pan_can_atlas_2018_gistic","ucs_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"ucs_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ucs_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"ucs_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ucs_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"ucs_tcga_pan_can_atlas_2018_log2CNA","ucs_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"ucs_tcga_pan_can_atlas_2018_mutations","ucs_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"urcc_mskcc_2016_cna","urcc_mskcc_2016"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status from targeted sequencing (IMPACT assay).",true,"urcc_mskcc_2016_mutations","urcc_mskcc_2016"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations (IMPACT)","Putative copy-number calls derived from IMPACT data. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"utuc_mskcc_2013_cna","utuc_mskcc_2013"
"MUTATION_EXTENDED","MAF","Mutations","Mutation status from targeted sequencing (IMPACT assay).",true,"utuc_mskcc_2013_mutations","utuc_mskcc_2013"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 80 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"uvm_tcga_gistic","uvm_tcga"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA Seq V2 RSEM)","Expression levels for 20532 genes in 80 um cases (RNA Seq V2 RSEM).",false,"uvm_tcga_rna_seq_v2_mrna","uvm_tcga"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq V2 RSEM)","mRNA z-Scores (RNA Seq V2 RSEM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"uvm_tcga_rna_seq_v2_mrna_median_Zscores","uvm_tcga"
"COPY_NUMBER_ALTERATION","CONTINUOUS","Relative linear copy-number values","Relative linear copy-number values for each gene (from Affymetrix SNP6).",false,"uvm_tcga_linear_CNA","uvm_tcga"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation (HM450) beta-values for genes in 80 cases. For genes with multiple methylation probes, the probe most anti-correlated with expression.",false,"uvm_tcga_methylation_hm450","uvm_tcga"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from whole exome sequencing. Mutation packager: UVM/20160128/gdac.broadinstitute.org_UVM.Mutation_Packager_Calls.Level_3.2016012800.0.0.tar.gz.",true,"uvm_tcga_mutations","uvm_tcga"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number from GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"uvm_tcga_pan_can_atlas_2018_gistic","uvm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","CONTINUOUS","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",false,"uvm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","uvm_tcga_pan_can_atlas_2018"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)","mRNA Expression Zscores, RSEM (Batch normalized from Illumina HiSeq_RNASeqV2)",true,"uvm_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","uvm_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","LOG2-VALUE","Log2 copy-number values","Log2 copy-number values for each gene (from Affymetrix SNP6).",false,"uvm_tcga_pan_can_atlas_2018_log2CNA","uvm_tcga_pan_can_atlas_2018"
"MUTATION_EXTENDED","MAF","Mutations","Mutation data from exome sequencing data that were compiled using handpicked individual MAFs taken from the individual tumor type AWG lists.",true,"uvm_tcga_pan_can_atlas_2018_mutations","uvm_tcga_pan_can_atlas_2018"
"COPY_NUMBER_ALTERATION","DISCRETE","Putative copy-number alterations from GISTIC","Putative copy-number calls on 129 cases determined using GISTIC 2.0. Values: -2 = homozygous deletion; -1 = hemizygous deletion; 0 = neutral / no change; 1 = gain; 2 = high level amplification.",true,"wt_target_2018_pub_gistic","wt_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (RNA-Seq RPKM)","Expression levels for 26136 genes in 136 wt cases (RNA-Seq RPKM).",false,"wt_target_2018_pub_rna_seq_mrna","wt_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (RNA Seq RPKM)","mRNA z-Scores (RNA Seq RPKM) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"wt_target_2018_pub_rna_seq_mrna_median_Zscores","wt_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","mRNA expression (microarray)","mRNA expression levels (Affymetrix microarray)",false,"wt_target_2018_pub_mrna","wt_target_2018_pub"
"MRNA_EXPRESSION","Z-SCORE","mRNA Expression z-Scores (microarray)","mRNA z-Scores (Agilent microarray) compared to the expression distribution of each gene tumors that are diploid for this gene.",true,"wt_target_2018_pub_mrna_median_Zscores","wt_target_2018_pub"
"METHYLATION","CONTINUOUS","Methylation (HM450)","Methylation beta-values (HM450 platform). For genes with multiple methylation probes, the probe least correlated with expression is selected.",false,"wt_target_2018_pub_methylation_hm450","wt_target_2018_pub"
"MUTATION_EXTENDED","MAF","Somatic mutations","Somatic mutation status from exome-sequencing on 124 samples",true,"wt_target_2018_pub_mutations","wt_target_2018_pub"
"MRNA_EXPRESSION","CONTINUOUS","microRNA expression","Expression levels for microRNAs.",false,"wt_target_2018_pub_mirna","wt_target_2018_pub"